FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 90 filers reported holding FATE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,589,773 | -23.7% | 333,986 | -8.6% | 0.04% | -26.3% |
| Q1 2023 | $2,082,700 | +7.5% | 365,386 | +90.4% | 0.06% | +3.6% |
| Q4 2022 | $1,936,644 | +37.4% | 191,937 | +205.2% | 0.06% | +10.0% |
| Q3 2022 | $1,409,000 | +552.3% | 62,888 | +621.2% | 0.05% | +400.0% |
| Q2 2022 | $216,000 | -76.4% | 8,720 | -43.5% | 0.01% | -86.3% |
| Q3 2021 | $914,000 | -18.0% | 15,428 | +14.1% | 0.07% | -28.4% |
| Q1 2021 | $1,114,000 | +10.8% | 13,516 | +22.3% | 0.10% | -3.8% |
| Q4 2020 | $1,005,000 | +53.9% | 11,055 | -66.9% | 0.11% | +171.8% |
| Q4 2019 | $653,000 | +264.8% | 33,373 | +81.7% | 0.04% | +225.0% |
| Q1 2018 | $179,000 | – | 18,369 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $7,163,616 | 2.64% |
| Redmile Group, LLC | 13,124,427 | $27,823,785 | 1.32% |
| Monaco Asset Management SAM | 1,847,944 | $3,917,641 | 1.16% |
| Casdin Capital, LLC | 2,050,000 | $4,346,000 | 0.48% |
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $1,484,000 | 0.21% |
| GCM Grosvenor Holdings, LLC | 495,916 | $1,051,342 | 0.21% |
| Nebula Research & Development LLC | 163,617 | $346,868 | 0.18% |
| Bellevue Group AG | 4,851,579 | $10,285,347 | 0.17% |
| Bruce & Co., Inc. | 200,000 | $424,000 | 0.14% |
| XTX Topco Ltd | 192,920 | $408,990 | 0.07% |